Managing wound complications such as skin and soft tissue infections is a well-known challenge for clinicians. Multiple interventions are typically required for optimal outcomes, and initiating the appropriate antimicrobial therapy for SSTIs within the first 48 hours is key. This program highlights the burden of infected wounds on patients and the healthcare system, explains the significance of antibiotic failure, particularly early in the course of therapy, and describes how DxWound provides a rapid, comprehensive assessment of the wound microbial environment, thus helping clinicians rapidly target antimicrobial therapy.
Title: DxWound: A DNA-Based Assessment of the Wound Microbial Environment
Date: Tuesday, Nov 14, 2017
Time: 10 AM PT / 1PM ET
Duration: 1 hour
Objectives: Upon completion of this session participants will be able to:
Pharm.D., BCPS (AQID) Lee Health
Following graduation from the University of Toledo Pharmacy School, Dr. Estrada completed a residency in critical care/infectious diseases and a fellowship in infectious diseases, also at the University of Toledo. She is the infectious diseases clinical specialist for Lee Health, co-chair of the antimicrobial stewardship committee, provides care to patients on the ID consult and HIV services and provides education to pharmacy and medical staff. She serves as preceptor for pharmacy students and PGY-1 pharmacy residents and is the program director for the PGY-2 Infectious Diseases Residency at Lee Health.
Dr. Estrada is an active member of multiple professional pharmacy organizations including ACCP, ASHP, FSHP and SIDP.
Pharm.D., MS, CSPI Millennium Health
Brandon Adkins, PharmD, MS, CSPI is a member of the Clinical Affairs team at Millennium Health. Brandon earned his PharmD from the University of North Carolina Eshelman School of Pharmacy and is an experienced pharmacist. Before entering pharmacy school, he obtained a Master’s Degree in Biochemistry from the University of Kentucky where his focus was analyzing and developing enzymatic assays. Dr. Adkins’ current interests include infectious disease, rapid diagnostics, pharmacogenomics, and toxicology.